Recently Updated Advisory Committee Materials

open here or see below please:
Recently Updated Advisory Committee Materials

Posted on April 06, 2012

Nonprescription Drugs Advisory Committee

• 2012 Meeting Materials, Nonprescription Drugs Advisory Committee¹

Anti-Infective Drugs Advisory Committee

• Slides for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee²
• John Bradley, M.D., Presentation for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and Nonprescription Drugs Advisory Committee (PDF – 196KB)³ (PDF - 183KB)
• James J. James, M.D., Dr.P.H., Presentation for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and Nonprescription Drugs Advisory Committee (PDF – 123KB)⁴ (PDF - 115KB)
• Robert R. Bass, M.D., FACEP, Presentation for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and Nonprescription Drugs Advisory Committee (PDF – 410KB)⁵ (PDF - 388KB)
• Susan Coller-Monarez, Ph.D., Presentation for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and Nonprescription Drugs Advisory Committee (PDF – 477KB)⁶ (PDF - 468KB)
• Ruth Lynfield, M.D., Presentation for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and Nonprescription Drugs Advisory Committee (PDF – 188KB)⁷ (PDF - 170KB)
• Linda J. Neff, Ph.D.,M.S.P.H, Presentation for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and Nonprescription Drugs Advisory Committee (PDF – 1.99MB)⁸ (PDF - 1.9MB)
• BARDA Presentations for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and Nonprescription Drugs Advisory Committee (PDF – 360KB)⁹ (PDF - 315KB)
• FDA Presentations for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and Nonprescription Drugs Advisory Committee (PDF – 301KB)¹⁰ (PDF - 150KB)
• Final Meeting Roster for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee¹¹ (PDF - 40KB)
• Final Agenda for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee¹² (PDF - 36KB)
• Final Questions for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee¹³ (PDF - 13KB)
• 2012 Meeting Materials, Anti-Infective Drugs Advisory Committee¹⁴

Endocrinologic and Metabolic Drugs Advisory Committee

• Webcast Information for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee¹⁵ (PDF - 16KB)
• Slides for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee¹⁶
• Guest Presentations for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (PDF – 4.21MB)¹⁷ (PDF - 3.1MB)
• FDA Backup Presentations for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (PDF – 188KB)¹⁸ (PDF - 172KB)
• FDA Main Presentations for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (PDF – 2.37MB)¹⁹ (PDF - 1.5MB)
• Final Meeting Roster for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee²⁰ (PDF - 20KB)
• Final Questions for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee²¹ (PDF - 13KB)
• 2012 Meeting Materials, Endocrinologic and Metabolic Drugs Advisory Committee²²
• Final Agenda for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee²³ (PDF - 18KB)